NM_002447.4:c.1838A>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002447.4(MST1R):​c.1838A>C​(p.Gln613Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,614,098 control chromosomes in the GnomAD database, including 230 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0067 ( 13 hom., cov: 33)
Exomes 𝑓: 0.011 ( 217 hom. )

Consequence

MST1R
NM_002447.4 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.683

Publications

13 publications found
Variant links:
Genes affected
MST1R (HGNC:7381): (macrophage stimulating 1 receptor) This gene encodes a cell surface receptor for macrophage-stimulating protein (MSP) with tyrosine kinase activity. The mature form of this protein is a heterodimer of disulfide-linked alpha and beta subunits, generated by proteolytic cleavage of a single-chain precursor. The beta subunit undergoes tyrosine phosphorylation upon stimulation by MSP. This protein is expressed on the ciliated epithelia of the mucociliary transport apparatus of the lung, and together with MSP, thought to be involved in host defense. Alternative splicing generates multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
MST1R Gene-Disease associations (from GenCC):
  • nasopharyngeal carcinoma, susceptibility to, 3
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0048924387).
BP6
Variant 3-49898093-T-G is Benign according to our data. Variant chr3-49898093-T-G is described in ClinVar as Benign. ClinVar VariationId is 403115.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00671 (1022/152286) while in subpopulation SAS AF = 0.039 (188/4826). AF 95% confidence interval is 0.0344. There are 13 homozygotes in GnomAd4. There are 540 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1022 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MST1RNM_002447.4 linkc.1838A>C p.Gln613Pro missense_variant Exon 5 of 20 ENST00000296474.8 NP_002438.2 Q04912-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MST1RENST00000296474.8 linkc.1838A>C p.Gln613Pro missense_variant Exon 5 of 20 1 NM_002447.4 ENSP00000296474.3 Q04912-1

Frequencies

GnomAD3 genomes
AF:
0.00674
AC:
1025
AN:
152168
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00596
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0389
Gnomad FIN
AF:
0.00367
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00901
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.0110
AC:
2758
AN:
251404
AF XY:
0.0134
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00408
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00360
Gnomad NFE exome
AF:
0.00849
Gnomad OTH exome
AF:
0.0101
GnomAD4 exome
AF:
0.0115
AC:
16787
AN:
1461812
Hom.:
217
Cov.:
32
AF XY:
0.0128
AC XY:
9316
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.00114
AC:
38
AN:
33480
American (AMR)
AF:
0.00432
AC:
193
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000880
AC:
23
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0476
AC:
4107
AN:
86258
European-Finnish (FIN)
AF:
0.00313
AC:
167
AN:
53342
Middle Eastern (MID)
AF:
0.0257
AC:
148
AN:
5768
European-Non Finnish (NFE)
AF:
0.0103
AC:
11408
AN:
1112010
Other (OTH)
AF:
0.0116
AC:
703
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
980
1959
2939
3918
4898
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00671
AC:
1022
AN:
152286
Hom.:
13
Cov.:
33
AF XY:
0.00725
AC XY:
540
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00192
AC:
80
AN:
41560
American (AMR)
AF:
0.00595
AC:
91
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5166
South Asian (SAS)
AF:
0.0390
AC:
188
AN:
4826
European-Finnish (FIN)
AF:
0.00367
AC:
39
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00900
AC:
612
AN:
68022
Other (OTH)
AF:
0.00425
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00880
Hom.:
33
Bravo
AF:
0.00594
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00907
AC:
78
ExAC
AF:
0.0111
AC:
1353
Asia WGS
AF:
0.0140
AC:
50
AN:
3478
EpiCase
AF:
0.0112
EpiControl
AF:
0.00865

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
14
DANN
Uncertain
0.98
DEOGEN2
Benign
0.19
T;.;.
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.082
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.86
D;D;D
MetaRNN
Benign
0.0049
T;T;T
MetaSVM
Benign
-0.39
T
MutationAssessor
Uncertain
2.2
M;.;M
PhyloP100
0.68
PrimateAI
Benign
0.29
T
PROVEAN
Uncertain
-2.5
D;.;D
REVEL
Uncertain
0.32
Sift
Benign
0.23
T;.;T
Sift4G
Benign
0.28
T;T;T
Polyphen
0.015
B;.;.
Vest4
0.40
MPC
0.27
ClinPred
0.027
T
GERP RS
4.5
Varity_R
0.25
gMVP
0.85
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35986685; hg19: chr3-49935526; COSMIC: COSV56570117; API